PLx Pharma Winddown Corp.

OTCPK:PLXP.Q Stok Raporu

Piyasa değeri: US$30.0

PLx Pharma Winddown Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

PLx Pharma Winddown has been growing earnings at an average annual rate of 54.6%, while the Pharmaceuticals industry saw earnings growing at 8.5% annually. Revenues have been declining at an average rate of 31.3% per year.

Anahtar bilgiler

54.6%

Kazanç büyüme oranı

68.0%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi6.0%
Gelir büyüme oranı-31.3%
Özkaynak getirisi-104.7%
Net Marj-606.9%
Son Kazanç Güncellemesi30 Sep 2022

Yakın geçmiş performans güncellemeleri

Recent updates

PLx Pharma Non-GAAP EPS of -$0.52 misses by $0.02, revenue of $0.48M

Aug 12

Is PLx Pharma (NASDAQ:PLXP) In A Good Position To Deliver On Growth Plans?

May 10
Is PLx Pharma (NASDAQ:PLXP) In A Good Position To Deliver On Growth Plans?

Most Shareholders Will Probably Find That The CEO Compensation For PLx Pharma Inc. (NASDAQ:PLXP) Is Reasonable

Nov 03
Most Shareholders Will Probably Find That The CEO Compensation For PLx Pharma Inc. (NASDAQ:PLXP) Is Reasonable

We're Interested To See How PLx Pharma (NASDAQ:PLXP) Uses Its Cash Hoard To Grow

Sep 23
We're Interested To See How PLx Pharma (NASDAQ:PLXP) Uses Its Cash Hoard To Grow

PLx Pharma: First Commercial Launch Makes It Attractive

Sep 17

PLx Pharma (NASDAQ:PLXP) Is In A Strong Position To Grow Its Business

Jun 15
PLx Pharma (NASDAQ:PLXP) Is In A Strong Position To Grow Its Business

Have Insiders Been Buying PLx Pharma Inc. (NASDAQ:PLXP) Shares?

Mar 05
Have Insiders Been Buying PLx Pharma Inc. (NASDAQ:PLXP) Shares?

PLx Pharma EPS misses by $0.10

Nov 16

Gelir ve Gider Dağılımı

PLx Pharma Winddown nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

OTCPK:PLXP.Q Gelir, gider ve kazançlar (USD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 225-28623
30 Jun 2211-41643
31 Mar 2210-48564
31 Dec 218-49404
30 Sep 217-61225
30 Jun 210-43134
31 Mar 210-3095
31 Dec 200-1794
30 Sep 200-11104
30 Jun 200-6104
31 Mar 200-10104
31 Dec 191-34105
30 Sep 191-2995
30 Jun 191-3485
31 Mar 191-2884
31 Dec 181184
30 Sep 181-1085
30 Jun 181-1095
31 Mar 181-9115
31 Dec 171-15104
30 Sep 170-9102
30 Jun 170-681
31 Mar 170-550
31 Dec 160-550
30 Sep 160-440
30 Jun 160-530
31 Mar 160-420
31 Dec 150-420
30 Sep 150-421
30 Jun 150-321
31 Mar 150-422
31 Dec 140-523
31 Dec 131-946

Kaliteli Kazançlar: PLXP.Q is currently unprofitable.

Büyüyen Kar Marjı: PLXP.Q is currently unprofitable.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: Insufficient data to determine if PLXP.Q's year-on-year earnings growth rate was positive over the past 5 years.

Büyüme Hızlandırma: Unable to compare PLXP.Q's earnings growth over the past year to its 5-year average as it is currently unprofitable

Kazançlar vs. Sektör: PLXP.Q is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-17.3%).


Özkaynak Getirisi

Yüksek ROE: PLXP.Q has a negative Return on Equity (-104.74%), as it is currently unprofitable.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin